Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Could it be Henoch-Schonlein purpura?
Australian Family Physician, 05/07/09
Lim DCE et al. - Henoch-Schonlein purpura is the most common form of systemic vasculitis in the paediatric setting with 90% of cases occuring in childhood. Although diagnosis in the primary care setting may be difficult, it is vital in order to avoid significant complications. This article outlines the pathogenesis, clinical manifestations and classification of Henoch-Schönlein purpura and details evidence based investigations and management. Henoch-Schonlein purpura is a self limiting disease characterised by a tetrad of clinical manifestations that vary in occurrence and order of presentation. There is no single diagnostic test to confirm Henoch-Schonlein purpura; diagnosis depends on recognition of clinical manifestations. Management usually occurs in the ambulatory setting and is mainly supportive. Priorities include symptom relief and preventive therapy to reduce the risk of complications.
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Patients perceptions of drug information given by a rheumatology nurse: A phenomenographic study
Musculoskeletal Care, 11/13/09
Monitoring methotrexate toxicity in juvenile idiopathic arthritis
Journal of Rheumatology, 11/18/09
Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis
Arthritis Care and Research , 11/02/09
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09
Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment
Pediatric Drugs, 11/11/09
Management of acute coronary syndrome in a case of Behcets disease
Blood Coagulation & Fibrinolysis, 11/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


